Literature DB >> 32105718

Solute carrier proteins and c-Myc: a strong connection in cancer progression.

Suman Panda1, Nilanjan Banerjee1, Subhrangsu Chatterjee2.   

Abstract

Solute carrier proteins (SLCs), the most understudied and second largest group of membrane proteins, maintain cellular metabolic homeostasis via the export and import of various solute, ions, metabolites, and even drugs. Given the importance of SLCs in maintaining normal cellular function, dysregulation of these proteins leads to the dramatic progression of cancers in neoplastic cells. The importance of these transporters as drug targets is gradually being realized by the scientific community. In this review, we describe the role of SLCs in hallmarks of cancer, focusing mainly on the connection between oncogenes (Myc) and SLCs in breast cancer. We also discussed the role of glucose and amino acid transporters in cancer cells and how they can be manipulated to develop anticancer therapies.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Year:  2020        PMID: 32105718     DOI: 10.1016/j.drudis.2020.02.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

1.  Long Noncoding RNA LINC00551 Suppresses Glycolysis and Tumor Progression by Regulating c-Myc-Mediated PKM2 Expression in Lung Adenocarcinoma.

Authors:  Li Wang; Huishan Wang; Bining Wu; Chun Zhang; Hualin Yu; Xueyan Li; Qinjue Wang; Xiaoli Shi; Chengfeng Fan; Dayu Wang; Jing Luo; Jinsong Yang
Journal:  Onco Targets Ther       Date:  2020-11-09       Impact factor: 4.147

2.  Upregulated Long Non-Coding RNA LL22NC03-N64E9.1 Promotes the Proliferation and Migration of Human Breast Cancer Cells by Silencing Kruppel-Like Factor 2 Expression.

Authors:  Weibin Lian; Xiaohua Jiang; Liangqiang Li; Qinglan Wang; Chengye Hong; Peidong Yang; Debo Chen
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

Review 3.  Emerging roles of the solute carrier family in pancreatic cancer.

Authors:  Zijian Wu; Jin Xu; Chen Liang; Qingcai Meng; Jie Hua; Wei Wang; Bo Zhang; Jiang Liu; Xianjun Yu; Si Shi
Journal:  Clin Transl Med       Date:  2021-03

4.  MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and in vitro experiments.

Authors:  Minde Li; Lin Zhou; Shaoyang Li; Linchun Fang; Le Yang; Xiao Wu; Chenxing Yang; Youyuan Bao; Sihai Lan; Zhigao Tong; Suyue Zheng; Bin Tang; Erming Zeng; Shenhao Xie; Cheng Chen; Tao Hong
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

5.  Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma.

Authors:  Jing Zhu; Yong Mou; Shenglan Ye; Hongling Hu; Rujuan Wang; Qing Yang; Yi Hu
Journal:  Front Cell Dev Biol       Date:  2021-12-15

6.  Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.

Authors:  Di Zheng; Zhun Wei; Weichun Guo
Journal:  Front Genet       Date:  2022-04-19       Impact factor: 4.772

7.  EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer.

Authors:  Debasis Nayak; Brenna Weadick; Avinash K Persaud; Radhika Raj; Reena Shakya; Junan Li; Moray J Campbell; Rajgopal Govindarajan
Journal:  iScience       Date:  2022-04-01

8.  Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer.

Authors:  Qunchen Zhang; Yutong Fang; Chuanghong She; Rongji Zheng; Chaoqun Hong; Chunfa Chen; Jundong Wu
Journal:  Exp Ther Med       Date:  2022-08-05       Impact factor: 2.751

Review 9.  MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells.

Authors:  Colleen Yi; Ai-Ming Yu
Journal:  Front Mol Biosci       Date:  2022-06-09

10.  Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer.

Authors:  Thomas W Grunt; Astrid Slany; Mariya Semkova; Ramón Colomer; María Luz López-Rodríguez; Michael Wuczkowski; Renate Wagner; Christopher Gerner; Gerald Stübiger
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.